Vaxzevria
- Licence status
- Withdrawn: 27/03/2024
- Active substances
- Chimpanzee Adenovirus encoding the SARS-CoV 2-Spike glycoprotein (ChAdOx1-S)
- Dosage Form
- Suspension for injection
- Licence number
- EU/1/21/1529/001-002
- Licence holder
- AstraZeneca AB
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- J07BX03 covid-19 vaccines
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 29/01/2021